HomeOGN • NYSE
add
Organon & Co
Previous close
$14.91
Day range
$14.22 - $15.07
Year range
$13.87 - $23.10
Market cap
3.70B USD
Avg Volume
2.92M
P/E ratio
4.30
Dividend yield
7.80%
Primary exchange
NYSE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.59B | -0.38% |
Operating expense | 561.00M | -6.66% |
Net income | 109.00M | -80.04% |
Net profit margin | 6.85 | -79.95% |
Earnings per share | 0.90 | 2.27% |
EBITDA | 411.00M | 9.89% |
Effective tax rate | 15.50% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 763.00M | 10.10% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 493.00M | — |
Shares outstanding | 257.54M | — |
Price to book | 7.81 | — |
Return on assets | — | — |
Return on capital | 9.25% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 109.00M | -80.04% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but gets a third of its revenue from the United States. Wikipedia
Founded
2020
Headquarters
Website
Employees
10,000
